Cargando…
Concomitant type I IFN and M-CSF signaling reprograms monocyte differentiation and drives pro-tumoral arginase production
BACKGROUND: Type I IFN-based therapies against solid malignancies have yielded only limited success. How IFN affects tumor-associated macrophage (TAM) compartment to impact the therapeutic outcomes are not well understood. METHODS: The effect of an IFN-inducer poly(I:C) on tumor-infiltrating monocyt...
Autores principales: | Tong, Yuanyuan, Zhou, Luyang, Yang, Limin, Guo, Panpan, Cao, Yanlan, Qin, F. Xiao-Feng, Liu, Jianghuai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354658/ https://www.ncbi.nlm.nih.gov/pubmed/30528455 http://dx.doi.org/10.1016/j.ebiom.2018.11.062 |
Ejemplares similares
-
IL-6/ERK signaling pathway participates in type I IFN-programmed, unconventional M2-like macrophage polarization
por: Yang, Limin, et al.
Publicado: (2023) -
MCTR3 reprograms arthritic monocytes to upregulate Arginase-1 and exert pro-resolving and tissue-protective functions in experimental arthritis
por: Pistorius, Kimberly, et al.
Publicado: (2022) -
Possible Role of Arginase-1 in Concomitant Tumor Immunity
por: Korrer, Michael J., et al.
Publicado: (2014) -
Correction: Possible Role of Arginase-1 in Concomitant Tumor Immunity
por: Korrer, Michael J., et al.
Publicado: (2016) -
Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation
por: Bialek-Waldmann, Julia K., et al.
Publicado: (2019)